Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Kinghawk Pharmaceutical is a China-based in vitro diagnostics company focused on the research, development, manufacturing, and commercialization of diagnostic reagents and related biotech products. The company is best known for blood typing reagents, rapid diagnostic test kits, ELISA products, clinical chemistry reagents, PCR-related molecular diagnostic products, and reference materials. Available company descriptions indicate it operates GMP manufacturing facilities in Beijing and has positioned itself as a domestic IVD supplier rather than a therapeutics developer. Kinghawk appears to be a commercial-stage healthcare company serving hospital and laboratory diagnostic markets, with activity centered in China and some international export presence.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Kinghawk Pharmaceutical.